Global Severe Asthma Treatment Market Poised For Significant Growth To Reach USD 36.18 Billion By 2033: FMI Study
North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.
Future Market Insights5d
Pharmaceutical Filtration Industry to Reach USD 45.08 Billion by 2033 at a CAGR of 8.9%
The global Pharmaceutical Filtration Market is set to experience robust growth over the next decade. Currently valued at US$ ...
Sustainability and Urbanization to Shape the Future of the Concrete Admixture Market | Study by Future Market Insights, Inc.
The global concrete admixture industry, valued at USD 18 billion in 2025, is set to grow at a 6.3% CAGR, reaching USD 33.2 ...
Sachet Packaging Market Set to Reach USD 16.9 Billion by 2035, Driven by High Demand in Food & Beverage Industry | Future Market Insights, Inc.
Increasing demand for lightweight and compact packaging in various sectors, such as food & beverages and pharmaceuticals is ...
Business Insider4d
Mersana Therapeutics: Promising Clinical Data and Strong Financial Position Justify Buy Rating
Analyst Charles Zhu from LifeSci Capital maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report) and keeping the price target at $8.00. Discover outperforming stocks and invest ...
Business Insider3d
Dyne Therapeutics: Positive Phase 1/2 Trial Results for DYNE-101 Lead to Buy Rating and Overweight Stock Recommendation
In a report released yesterday, Michael Ulz from Morgan Stanley reiterated a Buy rating on Dyne Therapeutics (DYN – Research Report), with a price target of $52.00. Discover outperforming stocks ...
The Irish News4d
“Armagh beat Derry, Kerry and Galway. You can be lucky once; you’re not lucky three times” - Armagh great Stevie McDonnell ponders 2025
THE legendary Stevie McDonnell doesn’t buy into the notion that Armagh were lucky to win last year’s All-Ireland - and insists Kieran McGeeney’s men won’t be derailed by a raft of new ...
Mena FN6d
Tenvie Therapeutics Launches With $200 Million To Deliver Breakthrough Small Molecule Therapies
Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics launched today with a commitment to transform the treatment of neurological diseases. The company combines a deep and diverse portfolio of ...
The Business Journals5d
Why biotech startup Tenvie sees promise in drugs from founders' old company
Tenvie Therapeutics Inc. is getting a set of small-molecule drugs — specifically, ones aimed at tamping down inflammation, rescuing metabolic dysfunction and restoring lysosomal function ...
FierceBiotech6d
Arch-backed Tenvie unveils with $200M and a neuro pipeline with assets from Denali
Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.
MM&M5d
Rx Rundown: Verdiva, Johnson & Johnson, Transcarent and more
OMNY Health is partnering with Scipher Medicine. Vertex Pharmaceuticals signed a three-year deal with Orna Therapeutics to use the RNA biotech’s delivery particles to develop its next iteration of ...
Benzinga.com6d
STAT+: Denali Therapeutics spinout raises $200M as neuro company resets
A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...